Security key
83086J200
Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)
CUSIP: 83086J200
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 33,945,050
- Total 13F shares
- 1,600
- Share change
- 0
- Total reported value
- $4,352
- Price per share
- $2.72
- Number of holders
- 1
Report period
Q4 2023
Institutions
1
Top holders
1
SKYE full security history
Newer quarter: Q1 2024
Skye Bioscience, Inc. SEC filings
Skye Bioscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83086J200
Recent filing periods:
Top shareholders of SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Versant Ventures III, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
501,925,802
|
$9,386,012 | — | 18 Aug 2023 | |
| Emerald Health Sciences Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
169,407,901
|
$3,167,928 | — | 10 Nov 2022 | |
| James L. Heppell |
3/4/5
|
Director |
—
class O/S missing
|
1,350,000
|
— | — | 14 Sep 2021 | |
| Sukhwinder Singh Rai |
3/4/5
|
Director |
—
class O/S missing
|
250,000
|
— | — | 05 Jan 2023 |
Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) as of Q4 2023
As of 31 Dec 2023,
Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1,600 shares.
The largest 1 holders included
Financial Gravity Asset Management, Inc..
This page lists
1
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q4 2025 Across Filers
Q4 2025 holders
49
Q4 2023 holders
1
Holder diff
-48
| Investor | Q4 2025 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.